Nov 05
Glybera is a drug meant to fight a very rare disorder: Lipoprotein lipase deficiency ,(LPLD) which prevents patients from metabolizing certain fat enzymes in the blood . It does this by modifying a patient’s DNA, and the European Commission has approved it for public use and it will be on sale in mid-2013. That makes it the first human gene therapy drug to be approved for use in the West (China’s been doing gene therapy since 2003.)
By Ubergizmo. Related articles: HIV virus receives double blow from new gene therapy , These Jeans Are 20% Plastic Bottles and Food Trays,
